Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cytokinetics Inc (CYTK) vs DraftKings Inc (DKNG) Price & Performance

Cytokinetics IncTrade
DraftKings IncTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs DraftKings Inc — how do they compare? Cytokinetics Inc trades at $76.66 (market cap $10.78B), while DraftKings Inc trades at $25.21 (market cap $12.05B). The key difference: Cytokinetics Inc and DraftKings Inc are close in size by market cap, and Cytokinetics Inc is trading nearer its 52-week high, DraftKings Inc nearer its low. Which is the better fit depends on your goals.

CYTKDKNG
Market Cap
$10.78B$12.05B
Sector
TechnologyConsumer Cyclical
52-Week High
$87.26$48.23
52-Week Low
$34.31$20.72
Enterprise Value
$10.88B$12.98B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cytokinetics Inc

Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.

The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.

DraftKings Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK

About DraftKings Inc

DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.

Read more on DKNG